Skip to main content
. 2019 Dec 30;21(1):256. doi: 10.3390/ijms21010256

Figure 2.

Figure 2

Macroscopic (a) and histological (b) analyses of tissue-engineered skin substitutes. Photos are of healthy (H) and psoriatic (P) substitutes and psoriatic substitutes treated with methotrexate (MTX), balsacone A (BA), balsacone B (BB), balsacone C (BC), (±)-balsacone K (BK) or (±)-iryantherin-D (BD).